Claritin patent hearing
This article was originally published in The Tan Sheet
Executive Summary
Federal Circuit Court of Appeals will hear oral arguments April 8 in Schering-Plough's appeal of lower court ruling that its desloratadine patents are invalid. New Jersey federal judge ruled in August that Schering cannot rely on patent claims covering desloratadine (Clarinex) to keep generic versions of Claritin off the OTC market before 2004 (1"The Tan Sheet" Aug. 12, 2002, p. 3)...
Federal Circuit Court of Appeals will hear oral arguments April 8 in Schering-Plough's appeal of lower court ruling that its desloratadine patents are invalid. New Jersey federal judge ruled in August that Schering cannot rely on patent claims covering desloratadine ( Clarinex ) to keep generic versions of Claritin off the OTC market before 2004 (1 (Also see "Desloratadine Patent Claims No Bar To Generic Claritin, Judge Says" - Pink Sheet, 12 Aug, 2002.), p. 3).... |